Abaloparatide does not have any absolute contraindications. Patients with severe renal impairment should use abaloparatide cautiously, as the drug is eliminated through the kidneys.

Abaloparatide use is not indicated in reproductive females. It is not recommended in patients with open epiphyses or genetic predispositions to osteosarcoma. Abaloparatide use is also not recommended in patients with Paget disease, idiopathic increased alkaline phosphatase levels, open epiphyseal plates, or bone malignancies. It is unknown whether any risks exist with abaloparatide in pregnancy, breastfeeding mothers, or breastfed infants or if there is any impact on milk production.